CytRx Full-year Loss Narrows

CytRx Corp. (CYTR) posted full-year net loss attributable to common stockholders of $4.8 million or $0.05 per share, narrower than $27.8 million or $0.30 per share in the year-ago period.

Revenue for full-year increased to $9.5 million from $6.3 million last year.

On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.04 per share on revenues of $370.00 thousand for the full-year ended December 31, 2009. Analysts' estimates typically exclude special items.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com